Visiting Dana-Farber? See our prescreening and mask requirements.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
When choosing a treatment center for acute lymphoblastic leukemia (ALL), you want a team of experienced and compassionate experts. The Adult Leukemia Program team at Dana-Farber Brigham Cancer Center has extensive experience caring for patients with ALL and are world leaders in advancing the treatment of leukemia.
Our team of experts concentrate exclusively on people with leukemia. While ALL is rare in adults, our Adult Leukemia Program cares for a high volume of patients with ALL and has experience caring for newly diagnosed and relapsed patients. Dana-Farber physicians are recognized as international leaders, and have helped establish standards for treating ALL in younger patients, ALL in older patients, ALL with the Philadelphia chromosome, and ALL that has come back after prior therapy.
We collaborate closely with transplant physicians in our Hematopoietic Stem Cell Transplantation Program — one of the largest and most experienced stem cell transplant programs in the world.
Expert Care and Treatment for Acute Lymphoblastic Leukemia Specialized program with expertise in cutting-edge leukemia diagnostics, treatment planning, management of therapy and complications. Care plans tailored to the needs of each patient, from the first meeting through long-term monitoring. Expertise in caring for: Young adults with ALL Older adults with ALL Adults with Philadelphia chromosome-positive ALL Relapsed and refractory disease Active clinical research program with clinical trials available for newly diagnosed and relapsed ALL patients based on age, disease sub-type, and treatment phase. Close collaboration with our internationally recognized bone marrow/stem cell transplantation program. Second opinion consultation for patients and physicians, nationally and internationally. Access to the latest diagnostics, such as molecular and genomic profiling, including the Rapid Heme Panel, available only to patients at Dana-Farber Brigham Cancer Center. The full expertise of two renowned medical centers: Dana-Farber Cancer Institute and Brigham and Women’s Hospital. We Treat You, Not Just Your Cancer Our entire team is here to support you throughout treatment and during recovery. You and your family have access to our full range of support services such as nutrition, social work, geriatrics, the Zakim Center for Integrative Therapies and Healthy Living, the Young Adult Program, and survivorship.
Our entire team is here to support you throughout treatment and during recovery. You and your family have access to our full range of support services such as nutrition, social work, geriatrics, the Zakim Center for Integrative Therapies and Healthy Living, the Young Adult Program, and survivorship.
New Patient Appointments 877-442-3324
Clinical Trials Questions?
877-DF-TRIAL (877-338-7425)
As a new Dana-Farber patient, find answers to questions about your first visit: what to bring, how to find us, where to park, and how to prepare.
We offer a wide range of services, from financial planning to creative arts to spiritual counsel, to support our patients through their cancer experiences.
See patient satisfaction survey results for different Dana-Farber locations collected by Press Ganey, an independent company experienced in patient satisfaction surveying.
The Blum Resource Center provides patients and family members with a comfortable environment to learn more about disease treatment and management.
Our nutrition experts help patients follow a healthy diet during and after cancer treatment.
The Leonard P. Zakim Center for Integrative Therapies and Healthy Living is dedicated to enhancing the quality of life for cancer patients and their families by incorporating complementary therapies into traditional cancer care.